UB-313

N/A

Report date: 2024/06/05 18:01:26

Base Information

Drug NameUB-313
Drug Alias NameUB-313
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVaxxinity Inc
China Registration ClassN/A

Develop Information

Active CompaniesVaxxinity Inc
Inactive CompaniesN/A
Active IndicationsMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A